carbamates and olaparib

carbamates has been researched along with olaparib in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chu, W; Chu, Y; Mach, RH; Makvandi, M; Mankoff, J; McDonald, ES; Zeng, C1

Other Studies

1 other study(ies) available for carbamates and olaparib

ArticleYear
Sigma-2 ligands and PARP inhibitors synergistically trigger cell death in breast cancer cells.
    Biochemical and biophysical research communications, 2017, 05-06, Volume: 486, Issue:3

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azabicyclo Compounds; Carbamates; Cell Death; Cell Line, Tumor; Drug Synergism; Epithelial Cells; Female; G2 Phase Cell Cycle Checkpoints; Gene Expression; Humans; Inhibitory Concentration 50; Mice; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Receptors, sigma

2017